Co-Authors
This is a "connection" page, showing publications co-authored by Francesco Violi and Pasquale Pignatelli.
Connection Strength
6.776
-
Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets. Platelets. 2021 Nov 17; 32(8):1009-1017.
Score: 0.950
-
Oxidative stress and cardiovascular disease: new insights. Kardiol Pol. 2018; 76(4):713-722.
Score: 0.759
-
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med. 2012 11 22; 367(21):2056.
Score: 0.525
-
Vitamin C inhibits platelet expression of CD40 ligand. Free Radic Biol Med. 2005 Jun 15; 38(12):1662-6.
Score: 0.309
-
Vitamin E for the treatment of cardiovascular disease: is there a future? Ann N Y Acad Sci. 2004 Dec; 1031:292-304.
Score: 0.302
-
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021 08; 16(5):1231-1237.
Score: 0.239
-
Low-Grade Endotoxemia and Thrombosis in COVID-19. Clin Transl Gastroenterol. 2021 06 04; 12(6):e00348.
Score: 0.237
-
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb Haemost. 2021 01; 121(1):102-105.
Score: 0.230
-
Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
Score: 0.224
-
Is Albumin Predictor of Mortality in COVID-19? Antioxid Redox Signal. 2021 07 10; 35(2):139-142.
Score: 0.222
-
Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19. Circ Res. 2020 07 17; 127(3):400-401.
Score: 0.222
-
SARS-CoV-2 and myocardial injury: a role for Nox2? Intern Emerg Med. 2020 Aug; 15(5):755-758.
Score: 0.220
-
Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost. 2020 Jun; 120(6):949-956.
Score: 0.220
-
Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach. Front Cardiovasc Med. 2019; 6:17.
Score: 0.203
-
Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient? J Am Coll Cardiol. 2018 02 13; 71(6):706-707.
Score: 0.189
-
Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly. Antioxid Redox Signal. 2017 Nov 10; 27(14):1083-1124.
Score: 0.185
-
Early decrease of oxidative stress by non-invasive ventilation in patients with acute respiratory failure. Intern Emerg Med. 2018 03; 13(2):183-190.
Score: 0.183
-
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet. J Am Heart Assoc. 2017 Jun 05; 6(6).
Score: 0.180
-
Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production. Thromb Haemost. 2017 07 26; 117(8):1558-1570.
Score: 0.179
-
Platelet isoprostane overproduction in diabetic patients treated with aspirin. Diabetes. 2012 Jun; 61(6):1626-32.
Score: 0.125
-
Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome. Intern Emerg Med. 2012 Jun; 7(3):219-27.
Score: 0.118
-
Alpha-linolenic acid-rich wheat germ oil decreases oxidative stress and CD40 ligand in patients with mild hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2006 Nov; 26(11):2577-8.
Score: 0.086
-
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? Drugs. 2020 Sep; 80(14):1383-1396.
Score: 0.056
-
Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis. Autoimmun Rev. 2019 May; 18(5):519-525.
Score: 0.051
-
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review. J Alzheimers Dis. 2019; 69(2):561-576.
Score: 0.050
-
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. Intern Emerg Med. 2018 12; 13(8):1349.
Score: 0.050
-
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation. Eur J Intern Med. 2018 08; 54:34-39.
Score: 0.048
-
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. Intern Emerg Med. 2018 08; 13(5):651-660.
Score: 0.048
-
Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. Circ J. 2018 04 25; 82(5):1286-1292.
Score: 0.047
-
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation. Am Heart J. 2018 06; 200:32-36.
Score: 0.047
-
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. Data Brief. 2018 Apr; 17:830-836.
Score: 0.047
-
Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation. Int J Cardiol. 2018 Mar 15; 255:69-73.
Score: 0.047
-
Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2017 Sep 19; 70(12):1455-1462.
Score: 0.046
-
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP. Sci Rep. 2017 06 19; 7(1):3797.
Score: 0.045
-
Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med. 2017 Apr; 12(3):387-406.
Score: 0.044
-
Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study. Int J Cardiol. 2017 Mar 15; 231:143-149.
Score: 0.044